 Axovant Sciences NASDAQ:AXON and Collegium Pharmaceutical NASDAQ:COLL are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, analyst recommendations, risk, earnings and profitability. Insider Institutional Ownership 7.6 of Axovant Sciences shares are held by institutional investors. Comparatively, ... 